Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7156 |
Intermediate Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD4080 |
Discontinued |
0.6872 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.6786 |
Remote Similarity |
NPD7486 |
Phase 1 |
0.6777 |
Remote Similarity |
NPD5703 |
Discontinued |
0.6763 |
Remote Similarity |
NPD6036 |
Suspended |
0.6748 |
Remote Similarity |
NPD2984 |
Phase 2 |
0.6724 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD3042 |
Approved |
0.6708 |
Remote Similarity |
NPD3043 |
Approved |
0.6695 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6695 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6653 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.6638 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6623 |
Remote Similarity |
NPD4599 |
Clinical (unspecified phase) |
0.6493 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.6488 |
Remote Similarity |
NPD2530 |
Phase 2 |
0.6488 |
Remote Similarity |
NPD7980 |
Clinical (unspecified phase) |
0.6475 |
Remote Similarity |
NPD3590 |
Clinical (unspecified phase) |
0.6458 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.6458 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.6455 |
Remote Similarity |
NPD3254 |
Phase 1 |
0.6455 |
Remote Similarity |
NPD3255 |
Phase 1 |
0.6446 |
Remote Similarity |
NPD5287 |
Discontinued |
0.6434 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.6367 |
Remote Similarity |
NPD534 |
Phase 2 |
0.6367 |
Remote Similarity |
NPD537 |
Phase 2 |
0.6342 |
Remote Similarity |
NPD5051 |
Phase 1 |
0.6333 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.6311 |
Remote Similarity |
NPD6643 |
Discontinued |
0.63 |
Remote Similarity |
NPD5107 |
Clinical (unspecified phase) |
0.6298 |
Remote Similarity |
NPD3541 |
Clinical (unspecified phase) |
0.6288 |
Remote Similarity |
NPD8442 |
Discontinued |
0.6281 |
Remote Similarity |
NPD4131 |
Phase 3 |
0.6271 |
Remote Similarity |
NPD3602 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD796 |
Phase 2 |
0.6224 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6221 |
Remote Similarity |
NPD5007 |
Approved |
0.6206 |
Remote Similarity |
NPD1900 |
Clinical (unspecified phase) |
0.6199 |
Remote Similarity |
NPD6023 |
Discontinued |
0.619 |
Remote Similarity |
NPD5567 |
Approved |
0.6157 |
Remote Similarity |
NPD4847 |
Phase 1 |
0.6154 |
Remote Similarity |
NPD5080 |
Phase 2 |
0.6148 |
Remote Similarity |
NPD949 |
Phase 1 |
0.6145 |
Remote Similarity |
NPD6856 |
Discontinued |
0.6141 |
Remote Similarity |
NPD2060 |
Approved |
0.6139 |
Remote Similarity |
NPD2929 |
Clinical (unspecified phase) |
0.6137 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.6136 |
Remote Similarity |
NPD4916 |
Discontinued |
0.6126 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.6126 |
Remote Similarity |
NPD2349 |
Phase 3 |
0.6113 |
Remote Similarity |
NPD5079 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD4132 |
Clinical (unspecified phase) |
0.6111 |
Remote Similarity |
NPD5165 |
Clinical (unspecified phase) |
0.6111 |
Remote Similarity |
NPD994 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD996 |
Phase 2 |
0.6109 |
Remote Similarity |
NPD6840 |
Approved |
0.6103 |
Remote Similarity |
NPD5052 |
Clinical (unspecified phase) |
0.61 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.6096 |
Remote Similarity |
NPD1954 |
Phase 1 |
0.6096 |
Remote Similarity |
NPD2535 |
Discontinued |
0.6092 |
Remote Similarity |
NPD1231 |
Phase 3 |
0.6083 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6062 |
Remote Similarity |
NPD5920 |
Clinical (unspecified phase) |
0.6044 |
Remote Similarity |
NPD3343 |
Phase 3 |
0.6038 |
Remote Similarity |
NPD6351 |
Discovery |
0.6016 |
Remote Similarity |
NPD6708 |
Discontinued |
0.6015 |
Remote Similarity |
NPD6244 |
Phase 3 |
0.6015 |
Remote Similarity |
NPD6243 |
Phase 3 |
0.6008 |
Remote Similarity |
NPD5458 |
Discontinued |
0.6008 |
Remote Similarity |
NPD7620 |
Phase 2 |
0.5992 |
Remote Similarity |
NPD2794 |
Discontinued |
0.5985 |
Remote Similarity |
NPD7273 |
Clinical (unspecified phase) |
0.5976 |
Remote Similarity |
NPD4048 |
Approved |
0.5975 |
Remote Similarity |
NPD3633 |
Approved |
0.5975 |
Remote Similarity |
NPD3634 |
Approved |
0.597 |
Remote Similarity |
NPD6473 |
Phase 1 |
0.5961 |
Remote Similarity |
NPD1273 |
Discontinued |
0.5958 |
Remote Similarity |
NPD3814 |
Phase 1 |
0.5957 |
Remote Similarity |
NPD2544 |
Clinical (unspecified phase) |
0.5954 |
Remote Similarity |
NPD5905 |
Phase 1 |
0.5945 |
Remote Similarity |
NPD6197 |
Approved |
0.594 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.5938 |
Remote Similarity |
NPD705 |
Clinical (unspecified phase) |
0.5934 |
Remote Similarity |
NPD7706 |
Clinical (unspecified phase) |
0.5924 |
Remote Similarity |
NPD2769 |
Approved |
0.5924 |
Remote Similarity |
NPD978 |
Clinical (unspecified phase) |
0.5922 |
Remote Similarity |
NPD3938 |
Phase 1 |
0.5922 |
Remote Similarity |
NPD4890 |
Phase 2 |
0.5911 |
Remote Similarity |
NPD6743 |
Phase 2 |
0.5911 |
Remote Similarity |
NPD6742 |
Phase 2 |
0.5907 |
Remote Similarity |
NPD6153 |
Approved |
0.5894 |
Remote Similarity |
NPD7117 |
Phase 2 |
0.5891 |
Remote Similarity |
NPD4925 |
Approved |
0.5889 |
Remote Similarity |
NPD5539 |
Phase 2 |
0.5872 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.587 |
Remote Similarity |
NPD6216 |
Approved |
0.5869 |
Remote Similarity |
NPD4995 |
Approved |
0.5869 |
Remote Similarity |
NPD4996 |
Approved |
0.5867 |
Remote Similarity |
NPD2786 |
Discontinued |
0.5865 |
Remote Similarity |
NPD1286 |
Suspended |
0.5862 |
Remote Similarity |
NPD3838 |
Phase 3 |
0.5862 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5857 |
Remote Similarity |
NPD7112 |
Discontinued |
0.5856 |
Remote Similarity |
NPD3849 |
Clinical (unspecified phase) |
0.5855 |
Remote Similarity |
NPD2762 |
Phase 2 |
0.5849 |
Remote Similarity |
NPD5833 |
Phase 1 |
0.5847 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.5847 |
Remote Similarity |
NPD5645 |
Phase 3 |
0.5844 |
Remote Similarity |
NPD4458 |
Phase 2 |
0.5844 |
Remote Similarity |
NPD4459 |
Clinical (unspecified phase) |
0.5839 |
Remote Similarity |
NPD5116 |
Phase 1 |
0.5833 |
Remote Similarity |
NPD5949 |
Phase 3 |
0.5827 |
Remote Similarity |
NPD2348 |
Phase 3 |
0.582 |
Remote Similarity |
NPD4070 |
Clinical (unspecified phase) |
0.5817 |
Remote Similarity |
NPD4358 |
Clinical (unspecified phase) |
0.5812 |
Remote Similarity |
NPD1334 |
Clinical (unspecified phase) |
0.5811 |
Remote Similarity |
NPD6848 |
Phase 1 |
0.5808 |
Remote Similarity |
NPD8106 |
Phase 2 |
0.5806 |
Remote Similarity |
NPD1297 |
Clinical (unspecified phase) |
0.5805 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.5804 |
Remote Similarity |
NPD7726 |
Phase 1 |
0.5801 |
Remote Similarity |
NPD5018 |
Phase 3 |
0.5794 |
Remote Similarity |
NPD5612 |
Discontinued |
0.5789 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.5789 |
Remote Similarity |
NPD1197 |
Approved |
0.5787 |
Remote Similarity |
NPD6501 |
Approved |
0.5787 |
Remote Similarity |
NPD3514 |
Clinical (unspecified phase) |
0.5787 |
Remote Similarity |
NPD6500 |
Approved |
0.5785 |
Remote Similarity |
NPD7705 |
Clinical (unspecified phase) |
0.5778 |
Remote Similarity |
NPD6482 |
Phase 1 |
0.5774 |
Remote Similarity |
NPD6536 |
Approved |
0.5774 |
Remote Similarity |
NPD6537 |
Approved |
0.5772 |
Remote Similarity |
NPD1287 |
Phase 2 |
0.5771 |
Remote Similarity |
NPD2813 |
Phase 3 |
0.5771 |
Remote Similarity |
NPD2812 |
Clinical (unspecified phase) |
0.5768 |
Remote Similarity |
NPD5802 |
Phase 2 |
0.5768 |
Remote Similarity |
NPD6572 |
Phase 2 |
0.5768 |
Remote Similarity |
NPD6573 |
Phase 3 |
0.5763 |
Remote Similarity |
NPD7757 |
Approved |
0.5763 |
Remote Similarity |
NPD7758 |
Approved |
0.576 |
Remote Similarity |
NPD6763 |
Discontinued |
0.5756 |
Remote Similarity |
NPD5008 |
Approved |
0.5754 |
Remote Similarity |
NPD6528 |
Phase 1 |
0.5753 |
Remote Similarity |
NPD4984 |
Phase 2 |
0.5753 |
Remote Similarity |
NPD4086 |
Phase 1 |
0.5751 |
Remote Similarity |
NPD2600 |
Approved |
0.5751 |
Remote Similarity |
NPD2601 |
Approved |
0.5751 |
Remote Similarity |
NPD2599 |
Approved |
0.5745 |
Remote Similarity |
NPD7684 |
Approved |
0.5745 |
Remote Similarity |
NPD7682 |
Approved |
0.5742 |
Remote Similarity |
NPD4187 |
Clinical (unspecified phase) |
0.5741 |
Remote Similarity |
NPD3886 |
Phase 1 |
0.5737 |
Remote Similarity |
NPD6202 |
Discontinued |
0.5736 |
Remote Similarity |
NPD2414 |
Clinical (unspecified phase) |
0.5732 |
Remote Similarity |
NPD4715 |
Clinical (unspecified phase) |
0.5732 |
Remote Similarity |
NPD4713 |
Clinical (unspecified phase) |
0.5732 |
Remote Similarity |
NPD4714 |
Approved |
0.5732 |
Remote Similarity |
NPD34 |
Approved |
0.5731 |
Remote Similarity |
NPD6772 |
Clinical (unspecified phase) |
0.5727 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.5726 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.5726 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.5721 |
Remote Similarity |
NPD4010 |
Discontinued |
0.572 |
Remote Similarity |
NPD7588 |
Discontinued |
0.572 |
Remote Similarity |
NPD722 |
Clinical (unspecified phase) |
0.572 |
Remote Similarity |
NPD8321 |
Discontinued |
0.572 |
Remote Similarity |
NPD4654 |
Phase 1 |
0.5714 |
Remote Similarity |
NPD7051 |
Phase 3 |
0.5714 |
Remote Similarity |
NPD7050 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD4157 |
Discontinued |
0.5714 |
Remote Similarity |
NPD7134 |
Clinical (unspecified phase) |
0.5709 |
Remote Similarity |
NPD7067 |
Approved |
0.5709 |
Remote Similarity |
NPD8271 |
Discontinued |
0.5709 |
Remote Similarity |
NPD7068 |
Approved |
0.5708 |
Remote Similarity |
NPD2127 |
Suspended |
0.5708 |
Remote Similarity |
NPD1234 |
Discontinued |
0.5704 |
Remote Similarity |
NPD7898 |
Clinical (unspecified phase) |
0.5704 |
Remote Similarity |
NPD7897 |
Phase 3 |
0.5703 |
Remote Similarity |
NPD4306 |
Phase 1 |
0.5703 |
Remote Similarity |
NPD5529 |
Phase 1 |
0.5703 |
Remote Similarity |
NPD5528 |
Clinical (unspecified phase) |
0.5699 |
Remote Similarity |
NPD5878 |
Approved |
0.5699 |
Remote Similarity |
NPD5875 |
Approved |
0.5697 |
Remote Similarity |
NPD3570 |
Phase 2 |
0.5697 |
Remote Similarity |
NPD2540 |
Clinical (unspecified phase) |
0.5695 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5693 |
Remote Similarity |
NPD3872 |
Phase 3 |
0.569 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.5688 |
Remote Similarity |
NPD3959 |
Phase 2 |
0.5688 |
Remote Similarity |
NPD3962 |
Phase 2 |
0.5684 |
Remote Similarity |
NPD7198 |
Clinical (unspecified phase) |
0.5684 |
Remote Similarity |
NPD3358 |
Approved |
0.5683 |
Remote Similarity |
NPD5644 |
Phase 1 |
0.568 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.5679 |
Remote Similarity |
NPD691 |
Discontinued |
0.5677 |
Remote Similarity |
NPD6906 |
Clinical (unspecified phase) |
0.5677 |
Remote Similarity |
NPD6605 |
Phase 3 |
0.5673 |
Remote Similarity |
NPD5911 |
Clinical (unspecified phase) |
0.5673
|
Remote Similarity |
NPD1838 |
Clinical (unspecified phase) |